Clinical Trial Update: A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants

View source ↗

Summary

A clinical trial evaluating Jyseleca (filgotinib) in Korean participants for rheumatoid arthritis and ulcerative colitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• Jyseleca (Filgotinib)

Snippet

Sponsor: Eisai Korea Inc. | Conditions: Arthritis, Rheumatoid, Colitis, Ulcerative | Status: RECRUITING